ClinTex是一个临床试验协作和数据分析平台,利用分布式账本技术(区块链)的优势。它利用以太坊公共区块链上的智能合约提供端到端分散式解决方案,该解决方案包含工具,以推动整个行业临床试验数据共享的协作,以及通过先进的临床数据审查进行临床试验的显着质量和运营改进,富有洞察力运营关键绩效指标(KPI),预测数据分析和机器学习(AI)。 ClinTex临床试验智能平台(ClinTex CTi)将极大地改善制药公司’在建立,实施,监督,审查和满足临床试验监管标准方面的运营和临床有效性。 ClinTex CTi平台的基础在于创建一个生态系统,该系统可实现所有临床试验数据视图的互操作性,并通过区块链技术,为存储和分析所选历史临床数据视图提供安全环境的独特能力。通过这种方式,ClinTex CTi平台提供了共享临床数据视图和开发数据分析解决方案的最佳环境,同时解决了所有利益相关方的隐私和安全问题。通过CTi平台,创建了一个由七个独立的分散应用程序组成的生态系统。这些应用程序将共同提供有价值的临床见解,利用新型预测分析工具和机器学习,为临床项目经理,临床试验医师,临床数据管理人员,药物警戒人员和现场监控人员提供便利。
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3-Q4 2020
验证 14%
注意。未经证实的成员实际上可能不是团队成员
There is enough material to suggest that ClinTex is aiming to address a real need within the clinical trial field. Tokenomics for the project are straightforward with minimal bonuses applicable and a clear team vesting period. The acceptance of Binance coin in the ICO adds another level of interest and, although no partnership is stated or implied, investors may feel it increases the possibility of a future listing opportunity with the exchange.
Maybe most importantly, an able team is backed by experienced advisors and together they have shown the foresight to partner with useful allies within the blockchain arena and realm of medical services.
The downside column is much shorter but it should be noted that there is currently no working product and the roadmap suggests that some of the infrastructure will not be fully available until well into 2020 which could hamper uptake of the platform.
The whitepaper states that one of the reasons ClinTex ClinTex has partnered with Intellimed is that they will “…deploy the CTi platform in academic clinical research settings.”
This suggests that a firm footing for the initial launch of the platform has been established so it is the forward momentum of ClinTex, that includes expected on-boarding of other pharmaceutical companies in mid-2019, that contributors to the ICO will need to judge.
Given that they have first mover advantage in this particular specialised arena, the fundamentals appear to outweigh the minor concern and marks ClinTex as an ICO worthy of serious consideration.
此优惠仅基于要约人提供的信息及其他公开信息。令牌销售或交换活动与ICO持有人完全无关,ICO持有人不参与(包括任何技术支持或促销)。仅显示ICO持有人无关的人员列出的令牌销售仅用于帮助客户跟踪总体令牌部门内发生的活动。这些信息并不意味着相当于您应该依赖的建议。在采取或不采取任何行动之前,您必须获得专业或专家的建议或进行自己的尽职调查。贡献者就收购令牌所订立的任何条款及条件属于其之间,而令牌及ICO持有人的发行人并非该等令牌的卖方。对于任何代币销售而言,ICOholder对第三方所作的任何陈述不承担任何法律责任,并且还必须直接针对此处列出的代币发行实体提出任何违反合同的请求。
如果您有任何疑问关于此令牌销售的性质,合法性或合法性或相关人员,请联系info@icoholder.com,了解有关您的疑虑的详细信息。